Update: PrescribeIT and TPP Type 1 Prescribing Requirements

At their November 2023 meeting, the TPP Steering Committee (TPPSC) approved continued exemption from the use of TPP prescription forms for TPP Type 1 drugs for prescribers and pharmacies using PrescribeIT to prescribe, transmit and receive electronically generated prescriptions. This interim approval is in place until Nov. 1, 2024.  

To meet TPP Alberta requirements, the TPPSC has asked PrescribeIT to continue to work towards mandatory inclusion and reporting of medical indication for Type 1 drug prescriptions. TPP will work with Canada Health Infoway towards solutions, and ongoing exemption will be dependent on progress towards this goal.

Under the conditional approval, prescribers and pharmacies enabled with PrescribeIT may continue using the system for TPP drug prescribing and do not need to use TPP prescription forms for Type 1 drugs (except for prescriptions for compounds containing type 1 TPP drugs) . As communicated previously, the following conditions must be met to qualify for the exemption:

• Both the prescriber and pharmacy must be PrescribeIT-enabled and using PrescribeIT for system-to-system communications, and

• The patient has choice in the pharmacy at which their prescriptions are filled, i.e., patients must not be directed to only PrescribeIT-enabled pharmacies.